Your browser doesn't support javascript.
loading
Quantifying heterogeneity of physical and mental health-related quality of life in chronic obstructive pulmonary disease patients in the United States.
Shah, Chintal H; Reed, Robert M; Villalonga-Olives, Ester; Slejko, Julia F; Eakin, Michelle N; So, Jennifer Y; Zafari, Zafar.
Afiliação
  • Shah CH; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy , Baltimore, MD, USA.
  • Reed RM; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine , Baltimore, MD, USA.
  • Villalonga-Olives E; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy , Baltimore, MD, USA.
  • Slejko JF; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy , Baltimore, MD, USA.
  • Eakin MN; Division of Pulmonary Medicine and Critical Care, Johns Hopkins University , Baltimore, MD, USA.
  • So JY; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine , Baltimore, MD, USA.
  • Zafari Z; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy , Baltimore, MD, USA.
Expert Rev Respir Med ; 14(9): 937-947, 2020 09.
Article em En | MEDLINE | ID: mdl-32500756
ABSTRACT

BACKGROUND:

Chronic obstructive pulmonary disease (COPD) is a heterogenous condition. This study aims to quantify the heterogeneity of Health-related Quality of Life (HRQoL), and identify subgroups with the lowest HRQoL, in COPD patients in the United States (US). Methods Data from 2008-2015 Medical Expenditure Panel Survey were used to examine the heterogeneity of HRQoL between different COPD subgroups using mixed-effects modeling and G-computation. The Physical Composite Summary (PCS) and Mental Composite Summary (MCS) scores from the Short-Form-12 questionnaire were utilized. We also compared the heterogeneity of HRQoL in our COPD cohort against that in a matched non-COPD cohort. Results The final sample consisted of 1,866 (weighted = 19,952,143) COPD patients with a mean age of 63.2 years (Standard error (SE)0.38), mean MCS score of 46.84 (SE0.35), and mean PCS score of 35.65 (SE0.32). The adjusted MCS and PCS scores ranged from 36.19 to 53.06, and from 25.52 to 48.27, respectively, for COPD subgroups. COPD patients had statistically significantly lower MCS and PCS scores by 4.61, and 5.86 points, respectively, compared to the matched non-COPD cohort, and MCS scores showed a wider variability in the COPD cohort. Conclusion Our study quantifies substantial heterogeneity of HRQoL in COPD in the US and provides evidence for prioritizing COPD subgroups with the lowest HRQoL for targeted interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article